Area of research
Pulmonary and Respiratory Medicine · Spectroscopy
Research interest
Research interests include Gastric Cancer Management and Outcomes, Advanced Proteomics Techniques and Applications, Mass Spectrometry Techniques and Applications, and MicroRNA in disease regulation.
Novel syngeneic model of anti-mouse CLDN18.2 CAR -T therapy for gastric cancer demonstrates a synergy with TGF-β and PD-L1 inhibitors
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY.
A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines.
Smad4 and p53 synergize in suppressing autochthonous intestinal cancer.
PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer.
MiR-30a and miR-200c differentiate cholangiocarcinomas from gastrointestinal cancer liver metastases.
Phase I and pharmacokinetic study of the vascular-disrupting agent CKD-516 (NOV120401) in patients with refractory solid tumors.